Evigrade
Moderate

Ciclosporin × Digoxin

Immunosuppressants. Calcineurin inhibitors×Cardiac glycosides (digitalis)

Mechanism

Ciclosporin inhibits P-glycoprotein in gut and renal tubules, reducing digoxin clearance. Digoxin AUC rises by 50–100%; toxicity risk is substantial.

Symptoms

Nausea, vomiting, loss of appetite, confusion, yellow-green halos around lights, arrhythmia (bigeminy, AV block). Symptoms appear earlier in older patients and chronic kidney disease.

Management

On ciclosporin start, reduce digoxin dose by 25–50% and check levels at 5–7 days. Target: 0.5–0.8 ng/mL. In parallel, monitor potassium and creatinine (ciclosporin is nephrotoxic and raises hyperkalaemia risk).

Check the full regimen, not just this pair

Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.

Open checker

Sources

All interactions